Baxter International, Inc. (BAX)
18.90
+0.64
(+3.53%)
USD |
NYSE |
Dec 11, 16:00
18.92
+0.02
(+0.08%)
After-Hours: 18:48
Baxter International Research and Development Expense (TTM): 518.00M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 1.943B |
| Solventum Corp. | 756.00M |
| Abbott Laboratories | 2.897B |
| Insulet Corp. | 270.80M |
| ResMed, Inc. | 339.08M |